In conclusion, our study suggested that ARHGEF39 exerts a promoting role in the viability, migration and invasion of ccRCC cells, which is probably realized via regulating the AKT/ERK signaling pathway. The gene discussed is AKT1; the disease is nonpapillary renal cell carcinoma.